Currently, contrast-enhanced MRI is the method of choice for treatment planning and follow-up in patients with meningioma. However, positron emission tomography (PET) imaging of somatostatin receptor subtype 2 (SSTR2) expression using 68Ga-DOTATATE may provide a higher sensitivity for meningioma detection, especially in cases with complex anatomy or in the recurrent setting. Here, we report on a patient with a multilocal recurrent atypical meningioma, in which 68Ga-DOTATATE PET was considerably helpful for treatment guidance and decision-making.
CITATION STYLE
Meißner, A. K., von Spreckelsen, N., Al Shughri, A., Brunn, A., Fuertjes, G., Schlamann, M., … Goldbrunner, R. (2022). Case report: Use of 68Ga-DOTATATE-PET for treatment guidance in complex meningioma disease. Frontiers in Oncology, 12. https://doi.org/10.3389/fonc.2022.1017339
Mendeley helps you to discover research relevant for your work.